Table 3.
Model | Hb Concentration | Inpatient Fatigue Level | High Fatigue (FACIT<27) | |||||
---|---|---|---|---|---|---|---|---|
β | 95% CI | p | OR | 95% CI | p | |||
|
||||||||
Minimum Hemoglobin | 1 | Minimum Hb (continuous) | 1.4 | (0.4, 2.3) | 0.005 | 0.9 | (0.8, 1.0) | 0.09 |
| ||||||||
7g/dL≤Hb<8g/dL* | −4.1 | (−6.6, −1.7) | <0.001 | 1.9 | (1.3, 2.8) | <0.001 | ||
Hb<7g/dL* | −4.2 | (−6.6, −1.6) | <0.001 | 1.5 | (1.1, 2.2) | 0.03 | ||
| ||||||||
2 | Minimum Hb (continuous) | 1.0 | (−0.1, 2.0) | 0.05 | 0.9 | (0.8, 1.1) | 0.41 | |
| ||||||||
7g/dL≤Hb<8g/dL* | −3.9 | (−6.3, −1.4) | 0.02 | 1.9 | (1.3, 2.7) | 0.001 | ||
Hb<7g/dL* | −3.2 | (−5.7, −0.6) | 0.02 | 1.3 | (0.9, 1.9) | 0.21 | ||
| ||||||||
Model | Hb Concentration | Inpatient Fatigue Level | High Fatigue (FACIT<27) | |||||
β | 95% CI | p | OR | 95% CI | p | |||
|
||||||||
Mean Hemoglobin | 1 | Mean Hb (continuous) | 0.22 | (−1.0, 1.5) | 0.71 | 1.0 | (0.9, 1.2) | 0.67 |
| ||||||||
8g/dL≤Hb<9g/dL# | −2.5 | (−4.9, −0.1) | 0.04 | 1.5 | (1.0, 2.1) | 0.03 | ||
Hb<8g/dL# | −2.4 | (−5.1, 0.4) | 0.09 | 1.2 | (0.8, 1.9) | 0.3 | ||
| ||||||||
2 | Mean Hb (continuous) | 0.4 | (−0.9, 1.6) | 0.6 | 1.0 | (0.9, 1.2) | 0.3 | |
| ||||||||
8g/dL≤Hb<9g/dL# | −2.5 | (−4.9, −0.2) | 0.04 | 1.5 | (1.1, 2.2) | 0.03 | ||
Hb<8g/dL# | −2.4 | (−5.1, 0.3) | 0.08 | 1.3 | (0.8, 1.9) | 0.27 |
Hb≥8g/dL referent group
Hb≥9g/dL referent group
Linear/Logistic Regression Model 1: Adjusted for age, sex, time of minimum Hb relative to measurement of fatigue, comorbidities
Linear/Logistic Regression Model 2: Adjusted for age, sex, time of minimum Hb relative to measurement of fatigue, # of cbc’s drawn during hospitalization, comorbidities
Comorbidities: myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, rheumatic disease, peptic ulcer disease, liver disease, diabetes, hemiplegia/paraplegia, renal disease, cancer, sickle cell anemia, gastrointestinal bleeding, depressive disorder